Challenges in NHL: Optimising first-line treatment in MCL

On behalf of the Scientific Committee, you are invited to join us for this LIVE interactive broadcast.

During this broadcast, the expert faculty will describe the optimal first-line treatments for different sub-groups of patients with mantle cell lymphoma (MCL), with a particular focus on translating clinical trial data into clinical practice.

During the live broadcast you will have the opportunity to ask questions and interact with the faculty.

Please REGISTER now for the live broadcast and to enable access to the on-demand version.

Learning objective:

After participating in this broadcast delegates should be able to:

• Describe the optimal first-line treatments for different sub-groups of patients with MCL

Faculty:

• Georg Hess (Germany)
• Christian Buske (Germany)
• Ana Marin Niebla (Spain)
• Toby Eyre (UK)
• Stefano Luminari (Italy)